Table 3.
Bivariate and multivariable logistic regression analysis of factors associated with self-reported behavior changes following the emergence of illicit fentanyl among PWUD in Vancouver, BC from December 2016-May 2017 (n = 999)
Characteristic | Odds Ratio | |
---|---|---|
Unadjusted (95% CI) | Adjusted (95% CI) | |
Age | 0.99 (0.98–1.00) | |
Male | 0.70 (0.54–0.91) | 0.76 (0.56–1.02) |
White | 1.11 (0.86–1.43) | |
≥High school education | 1.12 (0.86–1.45) | |
Homelessness* | 1.42 (1.02–1.96) | 1.26 (0.87–1.82) |
In a stable relationship*# | 0.87 (0.66–1.14) | |
Injection Drug use* | 3.41 (2.53–4.65) | 1.96 (1.37–2.80) |
Daily prescription opioid*† | 2.01 (0.93–4.42) | |
Daily heroin use*† | 1.91 (1.42–2.55) | 0.89 (0.62–1.28) |
Daily cocaine use*† | 1.93 (1.07–3.54) | 1.48 (0.77–2.84) |
Daily meth use*† | 1.11 (0.78–1.55) | |
Daily crack use*† | 1.18 (0.74–1.87) | |
Exclusive stimulant use*† | 0.47 (0.35–0.63) | 0.83 (0.58–1.20) |
Daily heroin & alcohol use*† | 1.85 (0.61–5.79) | |
Daily heroin &benzodiazepine use*† | 2.11 (0.46–10.76) | |
Daily heroin and stimulant use*† | 1.47 (0.93–2.33) | |
Daily alcohol use* | 0.66 (0.40–1.05) | |
Daily benzodiazepine use*† | 1.68 (0.96–2.97) | |
UDS positive for fentanyl | 2.47 (1.89–3.24) | 1.45 (1.04–2.03) |
Overdose* | 3.10 (2.21–4.38) | 2.28 (1.56–3.33) |
Opioid agonist therapy* | 2.22 (1.71–2.89) | 1.80 (1.34–2.43) |
Ever been diagnosed with mental health disorder | 1.21 (0.92–1.60) |
Group 1: no drug use behavior change; Group 2: drug use behaviors change;
Denotes activities in the previous six months.
Refers to any route of consumption (i.e., sniffing, snorting, smoking or injecting)
Legally married/common law/regular partner; UDS: urine drug screen, PWUD: people who use drugs; IQR: interquartile range, CI: Confidence Interval